CKBA

赛克乳香酸

Report date: 2026/05/06 16:38:53
NMEFirst In Class

Base Information

Drug NameCKBA
Drug Alias NameCKBA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsAcetyl-CoA carboxylase 1 inhibitorsAcetyl-CoA carboxylase 2 inhibitors
TargetsNuclear factor NF-kappa-B complexAcetyl-CoA carboxylase 1Acetyl-CoA carboxylase 2
Therapy Area/IndicationsPlaque psoriasisRosaceaVitiligo
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBCY Pharm Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBCY Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisRosaceaVitiligo
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A